ByteDance, the parent company of TikTok, is expanding into artificial intelligence-driven drug discovery through its unit, Anew Labs. This unit has begun presenting its AI-designed therapies at international conferences, showcasing advancements in biotech innovation. Operating from Shanghai, Singapore, and San Jose, California, Anew Labs highlights ByteDance's increasing investment in cutting-edge AI applications beyond social media.

ByteDance, the Chinese owner of TikTok, is pushing deeper into artificial intelligence with Anew Labs, a drug-discovery unit that has begun presenting its AI-designed therapies at international conferences. The unit – also known as Anew Therapeutics or ByteDance AI Drug Discovery – operates from Shanghai, Singapore and San Jose, California. Its official website listed 36 core members, as well as big names on its “scientific advisory board”: Liu Yongjun, former president of Innovent Biologics, Ji...